Drug companies spend billions of pounds chasing “the next big thing” – the wonder pill that will change the world and earn millions for its creators. Viagra, discovered by chance by pharmacists seeking a treatment for angina, is just such a drug.
Drug companies spend billions of pounds chasing “the next big thing” – the wonder pill that will change the world and earn millions for its creators. Viagra, discovered by chance by pharmacists seeking a treatment for angina, is just such a drug.
Pfizer, the US colossus that holds the patent, earned $1.6bn (£800m; E1.2bn) from Viagra sales last year. This is big money, even in an industry known for its blockbuster earnings.
But standing still is a recipe for disaster and Pfizer risks squandering Viagra's legacy. With fake Viagra flooding the internet and British rival, GlaxoSmithKline (GSK), working on a gel that could be widely available in chemists by 2009 (unlike Pfizer's little blue pill, which requires a doctor's prescription), Pfizer is playing a desperate game of catch up.
As The Business revealed last week, the company is discussing an over-the-counter version of Viagra aimed at boosting sales and seeing-off challenges from rivals such as GSK.
More articles from: | this section
Post this entry to: del.icio.us | Digg | Newsvine | NowPublic | Reddit
Advertisement
1,700 Unusual Christmas Presents Request Catalogue 01935 815 195 Quote SPEC10 for 10% discount www.presentfinder.co.uk
Pimilco based Florist with online ordering Web: www.olivebranch.net Tel: 020 7630 1868 Fax: 020 7233 8844
62 Shore Road, Warsash, Southampton, SO31 9FT Telephone: 01489 578867 Web site: www.ruffs.co.uk
Apollo Magazine | Corporate | Advertising | Privacy | Terms
Spectator, 22 Old Queen Street, London, SW1H 9HP
All Articles and Content Copyright ©2012 by The Spectator | All Rights Reserved
paul witten
January 19th, 2007 5:34pm Report this commentyou should have mentioned in the article that Glaxo's junior partner who brought the drug to Glaxo is a little known company called Futura.
Back to top